Antitumor evaluation of amaryllidaceae alkaloids on cancer cell lines: A literature review
More details
Hide details
Laboratory of Natural Products, Faculty of Health Sciences, University of Brasília, Brasília, BRAZIL
University of Gurupi, Paraíso do Tocantins, BRAZIL
Laboratory of Basic and Health Sciences, Federal University of Tocantins, Palmas, BRAZIL
Faculdade de Palmas, Palmas, BRAZIL
Online publication date: 2023-12-19
Publication date: 2024-01-01
Electron J Gen Med 2024;21(1):em562
Amaryllidaceae alkaloids have attracted significant attention in cancer research for their potential antitumor properties. To date, numerous studies have investigated the effects of these alkaloids on cancer cell lines, but a comprehensive synthesis of the existing evidence through a literature review is warranted. This article presents a comprehensive literature review aimed at evaluating the antitumor effects of amaryllidaceae alkaloids on various cancer cell lines and elucidating the underlying mechanisms of action. A search was conducted in major scientific databases, including Google Scholar, PubMed, Scopus, and Web of Science, to identify relevant studies published between 2013 and 2023. Studies that examined the antitumor effects of amaryllidaceae alkaloids on cancer cell lines were included in the review. Data were extracted, analyzed, and synthesized to provide an in-depth overview of the findings. The alkaloids exhibited potent cytotoxicity and suppressed cell proliferation in a concentration-dependent manner. Mechanistic investigations unveiled that amaryllidaceae alkaloids induced apoptosis, cell cycle arrest, and hindered angiogenesis in cancer cells. Moreover, they demonstrated favorable selectivity towards cancer cells, sparing normal cells, suggesting potential as targeted therapies. This literature review consolidates and critically appraises the available evidence on the antitumor effects of amaryllidaceae alkaloids on cancer cell lines. The findings underscore their potential as promising candidates for further exploration in cancer therapeutics. Future preclinical and clinical studies are vital to advance their development and translation into effective anticancer drugs.
Mathieu V, Laguera B, Masi M, et al. Amaryllidaceae alkaloids decrease the proliferation, invasion, and secretion of clinically relevant cytokines by cultured human colon cancer cells. Biomolecules. 2022;12(9):1267. PMid:36139106 PMCid:PMC9496155.
Danquah CA, Minkah PAB, Agana TA, et al. The phytochemistry and pharmacology of Tulbaghia, Allium, Crinum and Cyrtanthus: Talented Taxa from the Amaryllidaceae. Molecules. 2022;27(14):4475. PMid:35889346 PMCid:PMC9316996.
Habli Z, Toumieh G, Fatfat M, et al. Emerging cytotoxic alkaloids in the battle against cancer: overview of molecular mechanisms. Molecules. 2017;22(2):250. PMid:28208712 PMCid:PMC6155614.
Trujillo L, Bedoya J, Cortés N, et al. Cytotoxic activity of Amaryllidaceae plants against cancer cells: biotechnological, in vitro, and in silico approaches. Molecules. 2023;28(6):2601. molecules28062601 PMid:36985571 PMCid:PMC10058631.
Nair JJ, van Staden J. Pharmacological studies of Crinum, Ammocharis, Amaryllis and Cyrtanthus species of the South African Amaryllidaceae. South Afr J Botany. 2022;147:238-44.
Havelek R, Muthna D, Tomsik P, et al. Anticancer potential of Amaryllidaceae alkaloids evaluated by screening with a panel of human cells, real-time cellular analysis and Ehrlich tumor-bearing mice. Chem-Biol Interact. 2017;275:121-32. PMid:28756149.
Havelek R, Seifrtova M, Kralovec K, et al. The effect of Amaryllidaceae alkaloids haemanthamine and haemanthidine on cell cycle progression and apoptosis in p53-negative human leukemic Jurkat cells. Phytomedicine. 2014;21(4):479-90. 09.005 PMid:24182986.
Qiu Y, Fang B, Thuy NTT, et al. Narciclasine suppresses esophageal cancer cell proliferation and migration by inhibiting the FAK signaling pathway. Eur J Pharmacol. 2022;15(921):174669. 2021.174669 PMid:35248554.
Su J, Huo M, Xu F, et al. Molecular mechanism of lycorine in the treatment of glioblastoma based on network pharmacology and molecular docking. Naunyn Schmiedebergs Arch Pharmacol. 2023;5. 10.1007/s00210-023-02702-3 PMCid:PMC10497693.
Sancha SAR, Gomes AV, Loureiro JB, et al. Amaryllidaceae-Type alkaloids from Pancratium maritimum: apoptosis-inducing effect and cell cycle arrest on triple-negative breast cancer cells. Molecules. 2022;27(18):5759. PMid:36144504 PMCid:PMC9501014.
Castaneda C, Bravo K, Cortes N, et al. Amaryllidaceae alkaloids in skin cancer management: Photoprotective effect on human keratinocytes and anti-proliferative activity in melanoma cells. J Appl Biomed. 2023;21(1):36-47. PMid:37016777.
Souza ASQ, Sousa JAC, Pinto CS, et al. Untargeted GC/MS-based approach for identification of anti-inflammatory alkaloids from Hippeastrum elegans (Amaryllidaceae) using a human neutrophil model. J Pharm Biomed Anal. 2021;30(199):114061. 114061 PMid:33845386.
Ritomská A, Koutova D, Křoustková J, et al. Design of semisynthetic derivatives of the Amaryllidaceae alkaloid ambelline and exploration of their in vitro cytotoxic activities. Saudi Pharm J. 2023;31(8):101684. PMid:37457365 PMCid:PMC10345363.
Gasca CA, Moreira NCS, Almeida FC, et al. Acetylcholinesterase inhibitory activity, anti-inflammatory, and neuroprotective potential of Hippeastrum psittacinum (Ker Gawl.) herb (Amaryllidaceae). Food Chem Toxicol. 2020;145:111703. PMid:32858133.
Di Sotto A, Valipour M, Azari A, et al. Benzoindolizidine alkaloids tylophorine and lycorine and their analogues with antiviral, anti-inflammatory, and anticancer properties: promises and challenges. Biomedicines. 2023;11(10):2619. PMid:37892993 PMCid:PMC10603990.
Katoch D., Sharma U. Simultaneous quantification and identification of Amaryllidaceae alkaloids in Narcissus tazetta by ultra performance liquid chromatography-diode array detector-electrospray ionisation tandem mass spectrometry. J Pharm Biomed Anal. 2019;175:112750. PMid:31330284.
Hiensch AE, Mijwel S, Bargiela D, et al. Inflammation mediates exercise effects on fatigue in patients with breast cancer. Med Sci Sports Exerc. 2021;53(3):496-504. PMid:32910094 PMCid:PMC7886356.
Li C, Deng C, Pan G, et al. Lycorine hydrochloride inhibits cell proliferation and induces apoptosis through promoting FBXW7-MCL1 axis in gastric cancer. J Exp Clin Cancer Res. 2020;39:230. PMid:33126914 PMCid:PMC7602321.
Wang Y, Zhang D, Li C, et al. Narciclasine inhibits colorectal cancer cell growth by inducing apoptosis. Biomed Pharmacother. 2021;133:110968. j.gendis.2023.03.014 PMid:33189067.
Lee J, Park S, Kim H, et al. Inhibition of melanoma cell growth by galanthamine from lycoris radiata. Cancer Lett. 2021;507:37-46. PMid:33872695.
Fu LQ, Du WL, Cai MH, et al. The roles of tumor-associated macrophages in tumor angiogenesis and metastasis. Cell Immunol. 2020;353:104119. j.cellimm.2020.104119 PMid:32446032.
Luo Z, Yao X, Li M, et al. Modulating tumor physical microenvironment for fueling CAR-T cell therapy. Adv Drug Deliv Rev. 2022;185:114301. 10.1016/j.addr.2022.114301 PMid:35439570.
Li YR, Fang Y, Lyu Z, et al. Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies. J Transl Med. 2023;21:686. PMid:37784157 PMCid:PMC10546755.
Lv F, Li X, Wang Y. Lycorine inhibits angiogenesis by docking to PDGFRα. BMC Cancer. 2022;22(1):873. PMid:35948939 PMCid:PMC9364594.
Kingsley MK, Bhat BV, Badhe BA, et al. Narciclasine improves outcome in sepsis among neonatal rats via inhibition of calprotectin and alleviating inflammatory responses. Sci Rep. 2020;10:2947. s41598-020-59716-7 PMid:32076015 PMCid:PMC7031385.
Wang M, Liang L, Wang R. et al. Narciclasine, a novel topoisomerase I inhibitor, exhibited potent anti-cancer activity against cancer cells. Nat. Prod. Bioprospect. 2023;13:27. PMid:37640882 PMCid:PMC10462586.
Dasari S, Njiki S, Mbemi A, et al. Pharmacological Effects of Cisplatin Combination with Natural Products in Cancer Chemotherapy. Int J Mol Sci. 2022;28;23(3):1532. PMid:35163459 PMCid:PMC8835907.
Li Z, Zhou Q, Liu X, et al. Lycorine upregulates the expression of RMB10, promotes apoptosis and inhibits the proliferation and migration of cervical cancer cells. Int J Mol Med. 2022;50:145. ijmm.2022.5201 PMid:36367172 PMCid:PMC9662161.
Nair JJ, van Staden J. Cell cycle modulatory effects of Amaryllidaceae alkaloids. Life Sci. 2018;213:94-101. PMid:30179629.
Cao Z, Yu D, Fu S, et al. Lycorine hydrochloride selectively inhibits human ovarian cancer cell proliferation and tumor neovascularization with very low toxicity. Toxicol Lett. 2013;218(2):174-85. 01.018 PMid:23376478.
Zhang P, Yuan X, Yu T, et al. Lycorine inhibits cell proliferation, migration and invasion, and primarily exerts in vitro cytostatic effects in human colorectal cancer via activating the ROS/p38 and AKT signaling pathways. Oncol Rep. 2021;45(4):19. PMid:33649853 PMCid:PMC7879421.
Mondal A, Gandhi A, Fimognari C, et al. Alkaloids for cancer prevention and therapy: Current progress and future perspectives. Eur J Pharmacol. 2019;858:172472. PMid:31228447.
Heming CP, Muriithi W, Macharia LW, et al. P-glycoprotein and cancer: what do we currently know? Heliyon. 2022;22;8(10):e11171. 2022.e11171 PMid:36325145 PMCid:PMC9618987.
Țigu AB, Moldovan CS, Toma VA, et al. Phytochemical analysis and in vitro effects of Allium fistulosum L. and Allium sativum L. extracts on human normal and tumor cell lines: a comparative study. Molecules. 2021;26(3):574. PMid:33499159 PMCid:PMC7866094.
Nair JJ, van Staden J. cytotoxic agents in the minor alkaloid groups of the Amaryllidaceae. Planta Med. 2021;87(12-13):916-936. PMid:33706400.
Van Goietsenoven G, Mathieu V, Lefranc F, et al. Narciclasine as well as other Amaryllidaceae isocarbostyrils are promising GTP-ase targeting agents against brain cancers. Med Res Rev. 2013;33(2):439-55. PMid:22419031.
Journals System - logo
Scroll to top